Abstract 375: Mast Cell-Specific Regulation of Cardiomyocyte Contractility: Reevaluation of Role in Cardiac Function Following Myocardial Infarction
Inflammatory cells orchestrate post-ischemic cardiac remodeling after myocardial infarction (MI). Studies in Kit mutant mice suggest key roles for mast cells in post-ischemic tissue remodeling. However, Kit mutations affect multiple cell types of both immune and non-immune origin. The aim of this study was to address the impact of mast cells on cardiac function following MI, using selectively mast cell-deficient mice (Cpa3Cre/+ mice).
The number of mast cell progenitor (Lin-CD45+CD34+FcγRII/III+β7+) increased in the bone marrow and the white adipose tissue on day 3 after MI, infiltrated the heart on day 5 and differentiated to mature mast cells (Cd117+FcεRI+Sca1+) by day 7 in cardiac tissue. To assess the functional effect of mast cell infiltration, the cardiac function 14 days following MI was assessed in wild-type (WT) and 3 mast cells deficient mice models, the kitW/Wv mice, the Cpa3Cre/+ mice and mice treated with the degranulation inhibitor DSCG (50μg/g, once a day). There was a significant decrease of the left ventricular shortening fraction in all 3 mast cell deficient models compared to WT mice (1.4-, 1.6- and 2-fold respectively) that correlated with increased cardiomyocyte apoptosis in the kitW/Wv mice; and increased fibrosis in the DSCG-treated mice (n=8-14 per group, p<0.01 vs WT). Interestingly, in the Cpa3Cre/+ mice there were no differences on post-MI cardiac remodeling, but instead we observed a significant reduction in cardiomyocyte contractility (both cell shortening and maximal contracting velocity) (p<0.01) with no effect on Ca2+ transient peak or sarcoplasmic reticulum load.
This work re-evaluates existing mast-cell deficient models on their effect on cardiac remodeling and identifies a novel function for mast cells on modulation of cardiomyocyte contractility, Ca2+ cycling independently. Identification of the molecular regulators involved in the cardiac effect of mast cell will provide a new platform of regulators with potential therapeutic properties.
Author Disclosures: A. Ngkelo: None. A. Richart: None. J. Vilar: None. P. Marck: None. C. Heymes: None. H. Rodewald: None. J. Silvestre: None.
- © 2014 by American Heart Association, Inc.